Galectin Therapeutics Inc. (GALT)

[thefamilyman]

It looks like good news! And it probably is good news. But what is interesting is that this unmentioned trial shows up on ClinicalTrials.gov before the Phase 2 trials that the company has previously PRed. Unfortunately this is another example of Traber withholding information that should already have been PRed as a matter of course.

Traber has once again proved that he will withhold relevant information from his investors. They surprised us with bad news that should have been previously PRed (Cohort 2) and now they have surprised us with good news that should have been previously PRed. Is Traber intentionally trying to scare people away from this stock with his "management style" or did he graduate from the Clown School of Business Management?

Maybe Traber and Czirr are trying to prove that managerial incompetence doesn't matter if you have the right product... Where is the BOD?!?

Someone else posted about this on another message board and I thought I'd pass it on.

https://clinicaltrials.gov/ct2/show/NCT02407041

I hope that this is a sign of extreme confidence with plans going forward and won't result in a lot of dilution. Interesting that it showed up at the clinical trials site before any news from the company. Perhaps they've become a bit gun shy re: PR.
- Darwinian